Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04104685 · ClinicalTrials.gov registry record · Phase 2
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
A Phase 2 study, sponsored by Vyne Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 446
- Enrollment target
NCT04104685 is a Phase 2 study that has completed, run by Vyne Therapeutics. The registered enrollment target is 446 participants.
The verdict
NCT04104685, a Phase 2 study, has completed, sponsored by Vyne Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 446 participants
- Enrollment target
Study Summary
A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.
Interventions
- COMBINATION_PRODUCT FCD105
- DRUG 3% Minocycline Foam
- DRUG 0.3% Adapalene Foam
- OTHER Vehicle Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2020-03-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04104685
The ClinicalTrials.gov registry entry for NCT04104685 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vyne Therapeutics, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which FCD105 is the first listed.
NCT04104685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04104685 about?
NCT04104685 is a clinical study titled "A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.". A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.
What is the current status of trial NCT04104685?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 446 participants. The study started on 2019-09-18. Estimated completion is 2020-03-03.
What interventions are being tested in trial NCT04104685?
The interventions under investigation include: FCD105 (COMBINATION_PRODUCT), 3% Minocycline Foam (DRUG), 0.3% Adapalene Foam (DRUG), Vehicle Foam (OTHER).
Who is sponsoring clinical trial NCT04104685?
This trial is sponsored by Vyne Therapeutics, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.